All News

The approval was based on results from the phase 3 RECOURSE trial.

This is how my family and I were thrown into the cancer world.

Differing opinions on follow-up protocols can make it hard to advocate for oneself and to advise others.

Marianne Davies, from Smilow Cancer Hospital, Yale School of Nursing, provides an overview of immunotherapy-related side effects that patient with lung cancer may experience.

Kevin gives advice for giving advice.

At an 18-month analysis, the overall survival rate with the PD-1 inhibitor was 28 percent versus 13 percent with docetaxel in previously treated patients with squamous NSCLC.

The study was a secondary analysis of the PREDIMED trial, which involved 4,282 women in Spain aged 60 to 80 and at high risk of cardiovascular disease.

Researchers at UAB found that patients aged younger than 65 who were unmarried, lived in lower-income areas, and who were uninsured or Medicaid beneficiaries were at significantly higher risk of premature mortality.

The approval of Varubi was based on data from several phase 3 trials of the agent in more than 2,500 patients receiving various emetogenic chemotherapy agents.

Linda R. Duska, gynecologic oncologist, University of Virginia, discusses the Foundation for Women's Cancer.

Electroacupuncture produced larger placebo and smaller nocebo effects than did gabapentin for treating hot flashes among breast cancer survivors.

The breakthrough therapy designation will expedite the development and review of Opdivo in advanced renal cell carcinoma.

This reanalysis confirmed that there is no difference for a radiotherapy-first versus a chemotherapy-first strategy in this setting, but there is a major difference in long-term outcomes for molecular stratification independent of treatment.

These data were presented in late May at the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago.

Researchers are gaining new insight into long-term aspirin use for the prevention of colorectal cancer.

I wish my doctors knew more about the emotional aspects of cancer and were given more time with me.

More than 4,000 patients, survivors, loved ones, nurses and doctors gathered at Liberty State Park on September 12.

I have a rare mutation causing my cancer. Are there any others with ROS1 out there?

Patients with newly diagnosed glioblastoma are now being accepted at two institutions to enter a phase 2 study to assess the efficacy of the SurVaxM vaccine in combination with standard chemotherapy.

Which life is worth saving? More and more it depends on the cost of the drug used to treat your cancer.

The day came when I looked in the mirror and I didn't like what I saw. Here I was 5"7', and tipping the scales at 225 lbs.

A male breast cancer survivor's menu for mending.

The addition of Avastin (bevacizumab) to chemotherapy after initial therapy did not improve overall survival in patients with surgically resected early-stage non–small cell lung cancer.

My dad was diagnosed with Stage 4 lung cancer in February of 2014. His diagnosis included the BRAF mutation, which is still in the process of being researched for successful treatments.

Kim Statham Ringen, DVM DACVIM (Oncology), a CURE contributor who is currently surviving stage 4 non-small cell lung cancer, discusses the importance of meeting other cancer survivors.

It's hard to honor our bodies and respect what we need, especially when we are sick bodies living in a sea of the well.

Challenges to find healthy sleep come for a number of reasons, researchers are finding, including physical and psychological issues.

Overregulation of new drug development has driven up the cost of care and resulted in significant loss of human life by delaying the approval of effective medications, according to David J. Stewart.

Most patients younger than age 40 with lung cancer had tumors with mutations that can be targeted with existing therapies, according to a preliminary analysis of data from an ongoing study.

Returning to the mechanics of transplant, Kevin gives some details of the six-month milestone, but is unable to refrain from a bit of hopeful philosophy.